Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials – The Lancet
— Read on www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00432-3/fulltext